1083 related articles for article (PubMed ID: 26586646)
1. Lipoarabinomannan, and its related glycolipids, induce divergent and opposing immune responses to Mycobacterium tuberculosis depending on structural diversity and experimental variations.
Källenius G; Correia-Neves M; Buteme H; Hamasur B; Svenson SB
Tuberculosis (Edinb); 2016 Jan; 96():120-30. PubMed ID: 26586646
[TBL] [Abstract][Full Text] [Related]
2. Divergent effects of mycobacterial cell wall glycolipids on maturation and function of human monocyte-derived dendritic cells.
Mazurek J; Ignatowicz L; Kallenius G; Svenson SB; Pawlowski A; Hamasur B
PLoS One; 2012; 7(8):e42515. PubMed ID: 22880012
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response.
Briken V; Porcelli SA; Besra GS; Kremer L
Mol Microbiol; 2004 Jul; 53(2):391-403. PubMed ID: 15228522
[TBL] [Abstract][Full Text] [Related]
4. Recognition of Mycobacterial Lipids by Immune Receptors.
Ishikawa E; Mori D; Yamasaki S
Trends Immunol; 2017 Jan; 38(1):66-76. PubMed ID: 27889398
[TBL] [Abstract][Full Text] [Related]
5. Immunological hyporesponsiveness in tuberculosis: The role of mycobacterial glycolipids.
Correia-Neves M; Nigou J; Mousavian Z; Sundling C; Källenius G
Front Immunol; 2022; 13():1035122. PubMed ID: 36544778
[TBL] [Abstract][Full Text] [Related]
6. Critical roles for lipomannan and lipoarabinomannan in cell wall integrity of mycobacteria and pathogenesis of tuberculosis.
Fukuda T; Matsumura T; Ato M; Hamasaki M; Nishiuchi Y; Murakami Y; Maeda Y; Yoshimori T; Matsumoto S; Kobayashi K; Kinoshita T; Morita YS
mBio; 2013 Feb; 4(1):e00472-12. PubMed ID: 23422411
[TBL] [Abstract][Full Text] [Related]
7. Lipoarabinomannan mannose caps do not affect mycobacterial virulence or the induction of protective immunity in experimental animal models of infection and have minimal impact on in vitro inflammatory responses.
Afonso-Barroso A; Clark SO; Williams A; Rosa GT; Nóbrega C; Silva-Gomes S; Vale-Costa S; Ummels R; Stoker N; Movahedzadeh F; van der Ley P; Sloots A; Cot M; Appelmelk BJ; Puzo G; Nigou J; Geurtsen J; Appelberg R
Cell Microbiol; 2013 Apr; 15(4):660-74. PubMed ID: 23121245
[TBL] [Abstract][Full Text] [Related]
8. How Mycobacterium tuberculosis subverts host immune responses.
Józefowski S; Sobota A; Kwiatkowska K
Bioessays; 2008 Oct; 30(10):943-54. PubMed ID: 18800365
[TBL] [Abstract][Full Text] [Related]
9. Lipoarabinomannan in Active and Passive Protection Against Tuberculosis.
Correia-Neves M; Sundling C; Cooper A; Källenius G
Front Immunol; 2019; 10():1968. PubMed ID: 31572351
[TBL] [Abstract][Full Text] [Related]
10. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages.
Schlesinger LS; Hull SR; Kaufman TM
J Immunol; 1994 Apr; 152(8):4070-9. PubMed ID: 8144972
[TBL] [Abstract][Full Text] [Related]
11. Integrative Analysis of Human Macrophage Inflammatory Response Related to
Bade P; Simonetti F; Sans S; Laboudie P; Kissane K; Chappat N; Lagrange S; Apparailly F; Roubert C; Duroux-Richard I
Front Immunol; 2021; 12():668060. PubMed ID: 34276658
[No Abstract] [Full Text] [Related]
12. Mycobacteria-infected bystander macrophages trigger maturation of dendritic cells and enhance their ability to mediate HIV transinfection.
Mazurek J; Ignatowicz L; Källenius G; Jansson M; Pawlowski A
Eur J Immunol; 2012 May; 42(5):1192-202. PubMed ID: 22539293
[TBL] [Abstract][Full Text] [Related]
13. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response.
Reed MB; Domenech P; Manca C; Su H; Barczak AK; Kreiswirth BN; Kaplan G; Barry CE
Nature; 2004 Sep; 431(7004):84-7. PubMed ID: 15343336
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiota Regulates Mincle Mediated Activation of Lung Dendritic Cells to Protect Against
Negi S; Pahari S; Bashir H; Agrewala JN
Front Immunol; 2019; 10():1142. PubMed ID: 31231363
[TBL] [Abstract][Full Text] [Related]
15. Mannosylated structures of mycobacterial lipoarabinomannans facilitate the maturation and activation of dendritic cells.
Zhang S; Wu Q; Lei H; Zheng H; Zhou F; Sun Z; Zhao J; Yu X; Zhang S
Cell Immunol; 2019 Jan; 335():85-92. PubMed ID: 30527747
[TBL] [Abstract][Full Text] [Related]
16. DC-SIGN and mannosylated surface structures of Mycobacterium tuberculosis: a deceptive liaison.
Ehlers S
Eur J Cell Biol; 2010 Jan; 89(1):95-101. PubMed ID: 19892432
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell activation by sensing Mycobacterium tuberculosis-induced apoptotic neutrophils via DC-SIGN.
Hedlund S; Persson A; Vujic A; Che KF; Stendahl O; Larsson M
Hum Immunol; 2010 Jun; 71(6):535-40. PubMed ID: 20219612
[TBL] [Abstract][Full Text] [Related]
18. Mycobacteria target DC-SIGN to suppress dendritic cell function.
Geijtenbeek TB; Van Vliet SJ; Koppel EA; Sanchez-Hernandez M; Vandenbroucke-Grauls CM; Appelmelk B; Van Kooyk Y
J Exp Med; 2003 Jan; 197(1):7-17. PubMed ID: 12515809
[TBL] [Abstract][Full Text] [Related]
19. Navigating through the maze of TLR2 mediated signaling network for better mycobacterium infection control.
Yu X; Zeng J; Xie J
Biochimie; 2014 Jul; 102():1-8. PubMed ID: 24594065
[TBL] [Abstract][Full Text] [Related]
20. Pro- and anti-inflammatory cytokines in tuberculosis: a two-edged sword in TB pathogenesis.
Etna MP; Giacomini E; Severa M; Coccia EM
Semin Immunol; 2014 Dec; 26(6):543-51. PubMed ID: 25453229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
